Paul Datlinger

Paul Datlinger currently serves as Associate Director at Arc Institute since October 2024. Prior to this role, Paul was Group Leader of the Single Cell Innovation Lab at Xaira Therapeutics from June 2023 to November 2024 and held a similar position at Illumina as Group Leader of the Illumina Artificial Intelligence Lab from January 2023 to June 2023. Paul has extensive experience from CeMM, where a tenure spanned from October 2013 to December 2022, encompassing roles as Project Lead for CAR T screening, Postdoctoral Researcher focused on CAR T cells and single-cell technologies (scifi-RNA-seq), and Doctoral Researcher specializing in single-cell CRISPR screening (CROP-seq).